GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
Rating: MET
Buy $55

Metlife, Inc. (NYSE: MET) reiterated to Buy with price target $55 by Argus

Monday,  Sep 9, 2013  8:25 AM ET by Dave Ficere

Argus reiterated Metlife, Inc. (NYSE: MET) to Buy with price
target $55. Previously Argus rated Buy with price target $46 Metlife, Inc. (NYSE: MET) on 08/25/2011, when the stock price was $33.44.

MetLife, Inc. (MetLife) is a provider of insurance and other financial services with operations throughout the United States, and the regions of Latin America, Europe and Asia Pacific. Through the Company?s domestic and international subsidiaries and affiliates, it offers life insurance, annuities, automobile and homeowners insurance, retail banking and other financial services to individuals, as well as group insurance, reinsurance and retirement and savings products and services to corporations, and other institutions. MetLife operates in four business segments: Institutional, Individual, International and Auto & Home, as well as Corporate & Other. In May 2008, MetLife Bank, N.A., a unit of the Company, completed the acquisition of EverBank Reverse Mortgage LLC, from its parent, EverBank Financial Corp. EverBank Reverse Mortgage will be a wholly owned subsidiary of MetLife Bank. In May 2009, the Company sold Cova Corp., which is the parent company of Texas Life Insurance Co.

Argus Research is an independent research firm, and our business is producing, distributing and marketing high-quality investment and economic research. Our recommendations - BUY, HOLD and SELL - reflect the judgment of an analyst about a company's prospects as an investment in terms of value, expected growth and risks. Argus Research does not bring companies public, advise companies on mergers and acquisitions, broker trades, make markets in stocks or manage money. Our independence allows us to make critical judgments about companies that we might not be so free to make were we competing for a firm's underwriting business. Because we're not a broker/dealer, we don't have "inventory" of a stock that we have to move with a tainted recommendation. We have developed a six-point system for analyzing the stocks in our Universe of Coverage. We believe that this system



RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy